- Patent Title: Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists
-
Application No.: US15829680Application Date: 2017-12-01
-
Publication No.: US10538567B2Publication Date: 2020-01-21
- Inventor: Martin Bossart , Andreas Evers , Torsten Haack , Dieter Kadereit , Katrin Lorenz , Michael Wagner , Stefania Pfeiffer-Marek , Martin Lorenz
- Applicant: SANOFI
- Applicant Address: FR Paris
- Assignee: SANOFI
- Current Assignee: SANOFI
- Current Assignee Address: FR Paris
- Agency: Lathrop Gage LLP
- Agent James H. Velema, Esq.
- Priority: EP16306604 20161202
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/575 ; C07K14/605 ; A61K38/22 ; A61K45/06
Abstract:
The present invention relates to trigonal GLP-1/glucagon/GIP receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake.
Public/Granted literature
- US20180155406A1 COMPOUNDS AS PEPTIDIC TRIGONAL GLP1/GLUCAGON/GIP RECEPTOR AGONISTS Public/Granted day:2018-06-07
Information query
IPC分类:
